Higher-Acuity Care, Rate Stability and New M&A Priorities: Key Takeaways from the Q2 Earnings Season

The home health industry is at a pivotal moment, with operators weighing exciting new opportunities while simultaneously working through emerging challenges related to the COVID-19 virus.

Amedisys Inc. (Nasdaq: AMED), LHC Group Inc. (Nasdaq: LHCG), Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH) and other publicly traded providers discussed many of the industry’s biggest developments during their second-quarter earnings calls over the past few weeks. Home Health Care News listened into all of the updates, and there were four storylines that stood out to me most:

Sign up for HHCN + to read this exclusive content.

Individual Membership $400 per year

Purchase

Group
2–5 members
$380 per year*

Purchase

Need more than 5 members? Contact us for more information.

* per member

Already a member?

The post Higher-Acuity Care, Rate Stability and New M&A Priorities: Key Takeaways from the Q2 Earnings Season appeared first on Home Health Care News.